Protean BioDiagnostics Sets Sights on Transforming Diagnostics for Breast Cancer Patients
Protean BioDiagnostics, an Orlando based innovative diagnostics company is focusing its test development efforts on helping patients with breast cancer using innovative new approaches for cancer diagnostics.
Dr. Magliocco, Protean’s CEO, said “Protean BioDiagnostics is focused on making the latest advances in precision cancer diagnostics available to all patients, especially those who are currently under-serviced due to living in remote areas and being treated in community cancer centers”
Protean BioDiagnostics has developed a unique precision cancer system “Oncology MAPS™ to facilitate easy access to the complicated tests now needed to optimally diagnose and manage patients with breast cancer.
Treatments for breast cancer are rapidly changing with many new therapeutic options including targeted therapies and immune therapies. Proper use of these effective new treatments require use of complex testing including special molecular diagnostic services, genetic analysis, special blood testing, and novel stains on a patients breast cancer tissue. Unfortunately these new laboratory tests are currently not available to all patients and can be confusing for oncologists to use creating a gap in access to precision medicine for many cancer patients.
“Protean BioDiagnostics Oncology MAPS™ system makes accessing these complex tests easy” said Dr Magliocco. “Protean BioDiagnostics provides access to complete cancer laboratory diagnostic services under the highest CAP CLIA standards in its new Orlando Laboratory facility.
“It’s truly a revolutionary time for precision oncology with incredible advances improving outcomes for women with breast cancer” said Dr Magliocco. “However, accessing these novel therapies are contingent on availability of high quality and complete laboratory diagnostic services”.
Protean BioDiagnostics is focused on ensuring these services are easily available to all breast cancer patients and their doctors wherever they live” Protean’s Oncology MAPS™ system is informed by current best evidence based guidelines for testing and is continuously updated with new advances enabling oncologist to stay up to date with testing.